Emerging treatment for Sjögren's disease: a review of recent phase II and III trials.

Robert I FoxCarla M FoxSara S McCoy

Published in: Expert opinion on emerging drugs (2023)

This review allows updates the reader on the multitude of recent phase II/III clinical trials. We speculate on how subtypes of SjD will drive future therapeutic targeting and inform pathogenesis.

Keyphrases

phase ii
clinical trial
open label
phase iii
double blind
cancer therapy
randomized controlled trial
disease activity
drug delivery
replacement therapy